DURHAM, N.C. – EA, long known as an industry leader in adopting new genomic technologies announced today that is has begun offering sequencing services on Pacific Biosciences’ PacBio RS system. EA is the first US commercial service provider to offer sequencing on this platform and PacBio selected EA to be their recommended North American commercial […]
SEATTLE, WA – Stratos Genomics Inc. today announced $2.1 million of funding to continue development of its ultra-low-cost nucleic acid sequencing method for whole genome analysis and molecular diagnostics. The funds are provided by existing shareholders as an “up round” to August 2010’s $4 million financing and under the same Series-A terms. “We are fortunate […]
CARLSBAD, Calif. – Life Technologies Corporation today announced that preliminary data from DNA sequencing performed in cooperation with the University Hospital Muenster, Germany, on the Ion Personal Genome Machine (PGM™) strongly suggests that the bacterium at the root of the deadly outbreak in Germany is a new hybrid type of pathogenic E. coli strains. The […]
MOUNTAIN VIEW, Calif. – Complete Genomics, Inc. (Nasdaq: GNOM) announced the closing of its underwritten public offering of 6,325,000 shares of its common stock at $12.50 per share, which includes the exercise in full by the underwriters of their option to purchase up to 825,000 additional shares at the public offering price, less the underwriting […]
Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has today announced the release of its next generation targeted sequencing service. With an emphasis on flexibility, expert project design and advanced data analysis, the new offering takes advantage of OGT’s high-quality processes and in-house bioinformatics experience to provide […]
CARLSBAD, Calif. – Life Technologies Corporation (NASDAQ: LIFE) today announced it is now shipping the Ion Total RNA-Seq Kit for the Ion Personal Genome Machine (PGM™) sequencer, a solution that provides a fast, affordable, easy-to-use alternative to microarrays for transcript expression analysis. The Ion PGM sequencer puts RNA-Seq within the reach of any lab, enabling […]
MOUNTAIN VIEW, Calif. – Complete Genomics, Inc. (Nasdaq: GNOM) announced the pricing of its underwritten public offering of 5,500,000 shares of its common stock at $12.50 per share. Complete Genomics has granted the underwriters a 30-day option to purchase up to 825,000 additional shares at the public offering price, less the underwriting discounts and commissions, […]
CARLSBAD, Calif. – Addressing the issue of data overload from next-generation sequencers, Life Technologies Corporation (NASDAQ: LIFE) today launched its LifeScope™ 2.0 Genomic Analysis Software, a significantly enhanced bioinformatics system for analyzing data from genomic sequencing instruments to study human disease such as cancer. Information overload A single next generation sequencing instrument can generate nearly […]
SOUTH SAN FRANCISCO, Calif. – Fluidigm Corporation (NASDAQ:FLDM) today announced that the Broad Institute of MIT and Harvard has purchased an Access Array™ System to automate its sample preparation for targeted resequencing. The Access Array System enhances the capabilities of powerful next-generation sequencing platforms by allowing the preparation of several sample libraries in parallel. The […]
SEATTLE, WA – Stratos Genomics Inc today announced it has been granted US Patent 7,939,259 titled “High Throughput Nucleic Acid Sequencing by Expansion.” Sequencing by Expansion™ (SBX™) is a method for converting DNA into a more easily-read polymer called an Xpandomer™. Xpandomers encode DNA base sequence information with high signal-to-noise reporters optimally positioned along the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
